Menu
04 Oct 2023 | 6:37 AM
Research Report
Daily

Equity Research Report: Religare Morning Digest

We reiterate our cautious view and suggest continuing with hedged positions. Also, maintain stock specific trading approach.
12 Dec 2018 | 07:00 AM
TAG's

  • Aurobindo Pharma’s wholly-owned subsidiary Helix Healthcare BV, Netherlands, has inked an agreement with China-based Shandong Luoxin Pharmaceutical (Luoxin) to establish a JV company in China As per the agreement, Helix will invest UDD 15mn and Luoxin will invest USD 35mn in the proposed JV in the form of equity in a phased manner.
  • Strides Pharma Science announced that its joint venture firm has received approval from US health regulator for Albendazole tablets, used in treatment of certain infections caused by tapeworm.
  • Mindtree.org, the social inclusion platform of Mindtree, announced the successful implementation of its five digital platforms designed to build inclusive societies and create more opportunities for independent entrepreneurs in India and elsewhere.
RESEARCH SECTION
INTRADAY TRADING CALLS
RESEARCH REPORTS
PRODUCTS & SERVICES
MARKET & NEWS
RELIGARE ONLINE
Important links
LATEST RESEARCH REPORTS
Agri Fundamental & Technical Report| Agri Fundamental & Technical Report | Weekly Report ( Metals & Energy) Jan 21-Jan 25 2019| Weekly Report ( Metals Energy ) 7th Jan 2019 11th Jan 2019| Daily Forex Report | Daily Forex Report | Daily Forex Report | Agri Fundamental and Technical report | Daily Forex Report | Agri Fundamental and Technical Report
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

Filing complaint on SEBI SCORES – Easy & quick
a. Register on SCORES portal
b. Mandatory details for filing complaints on SCORES - Name, PAN, Address, Mobile Number, E-mail ID
c. Benefits - Effective Communication & speedy redressal of the grievances

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.

Kindly update your aadhar with us here. UPDATE AADHAAR
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Broking Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Broking Business of Religare Securities Ltd ( RSL) has been transferred and vested in Religare Broking Limited ( RBL) , pursuant to NCLT order.
  • Religare Broking Limited (RBL) :
  • SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235; BSE CM, F&O,CD, CO Code: 3004 Clearing No: 3004 MSEI CM, F&O, CD, TM Code: 1051 Clearing Member No. 51  | MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809.
  • Depository Participant –
  • NSDL: DP ID: IN 301774  |  SEBI Regn. No: IN-DP-385-2018  |  CDSL DP ID: 30200  |  SEBI Regn. No: IN-DP-385-2018
  • Religare Broking Limited (RBL):
  • Research Analyst SEBI Regi. No.: INH100006977
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • Neml Member ID - 10042
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)